Trial Profile
Clinical trial of an adalimumab biosimilar (GB 232; BCD 100).
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 15 May 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Autoimmune disorders
- Focus Adverse reactions
- Sponsors Genor Biopharma
- 15 May 2015 New trial record